Randomized control trail to investigate if treatment effect for low back pain is enhanced by using LumoBack in addition to the McKenzie approach

Randomized control trail to investigate if treatment effect for low back pain is enhanced by using LumoBack in addition to the McKenzie approach - Effectiveness of interventions based on Mechanical Diagnosis and Therapy (MDT) and based on MDT with a posture biofeedback device, LumoBack, for non-specific low back pain: a randomized control trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018380

Enrollment

Registered

2015-08-01

Start date

2015-08-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-specific low back pain

Interventions

Participants in the MDT only group will be treated with routine MDT assessments and treatments for 6 weeks. The intervention will be undertaken 1-2 times a week. Postural education in sitting will be

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who will be diagnosed as non-specific low back pain by a medical doctor Those who are using an smart phone Symptom duration for one month or more

Exclusion criteria

Exclusion criteria: Those with history of back or lower quadrant surgery or trauma within the past 6 months Those with history of trauma within the past 6 months Those with history of nerve root block within the past 4 weeks Those with history of neuropathic pathology such as diabetes or polyneuropathies Those with history of vascular disease in the lower extremities Those with systemic disease Those with inflammatory arthropathies Those with contraindications to manual therapy techniques such as fracture, infection or severe osteoporosis Those who cannot communicate well for some reasons Those without symptoms reduction or centralization by loading in the direction of lumbar extension

Design outcomes

Primary

Measure	Time frame
Pain intensity will be assessed with the P4 (0-40). The magnitude of disability will be assessed with the Oswestry Disability Index Japanese version, Patient specific functional scale, and the MOS 36-Item Short-Form Health Survey Japanese version. Overall improvement will be measured using the Global Perceived Change Scale (GPC) where patients score their perceived change after the treatment on a 7-point scale ranging from: 1 (completely recovered) to 7 (worse than ever).	—

Measure

Time frame

Pain intensity will be assessed with the P4 (0-40). The magnitude of disability will be assessed with the Oswestry Disability Index Japanese version, Patient specific functional scale, and the MOS 36-Item Short-Form Health Survey Japanese version. Overall improvement will be measured using the Global Perceived Change Scale (GPC) where patients score their perceived change after the treatment on a 7-point scale ranging from: 1 (completely recovered) to 7 (worse than ever).

—

Countries

Japan

Contacts

Public ContactHiroshi Takasaki

Saitama Prefectural University Physical Therapy

takasaki-hiroshi@spu.ac.jp0489734706

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026